Innate Pharma SA

Home » Innate Pharma SA

IPO

Innate Pharma SA

Biotechnology

We are a biotechnology company focused on discovering, developing and commercializing first-in-class therapeutic antibodies designed to harness the immune system for the treatment of oncology indications with significant unmet medical need.

Symbol

IPHA

Price Range
$7.50 - $7.50

Final Shares
10,666,666

Anticipated Date
October 17, 2019

Underwriters
CITIGROUP GLOBAL MARKETS INC.,LEERINK SWANN & COMPANY

This offering is no longer available

To view the prospectus for Innate Pharma SA IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253